January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Sacituzumab govitecan vs platinum-based chemotherapy for Urothelial Carcinoma – ESMO
Dec 19, 2024, 12:33

Sacituzumab govitecan vs platinum-based chemotherapy for Urothelial Carcinoma – ESMO

ESMO posted on X about recent paper by Petros Grivas et al., titled “LBA9 TROPiCS-04, a randomized phase III study of sacituzumab govitecan (SG) vs chemotherapy (CT) in pretreated advanced urothelial carcinoma (aUC): Overall survival (OS) and safety analysis” published on ESMO Annals of Oncology.

Authors: P. Grivas, T.B. Powles, C. Vulsteke, M. Gross Goupil, S.H. Park, A. Necchi, M. De Santis, I. Duran, R. Morales Barrera, J. Guo, C.N. Sternberg, J. Bellmunt, P.J. Goebell, F. Boateng, M. Sierecki, L. Wang, C. Sima, J. Waldes, S.T. Tagawa, Y. Loriot

Sacituzumab govitecan vs platinum-based chemotherapy for Urothelial Carcinoma - ESMO

ESMO Asia24: The results of the phase III TROPiCS-04 study reveal that sacituzumab govitecan, while active in pre-treated patients with advanced Urothelial Carcinoma, did not significantly improve OS or PFS compared to platinum-based chemotherapy.”

Read Further.